Modulated iontophoretic delivery of small and large molecules through microchannels.

The objective of this work was to modulate transdermal drug delivery by iontophoresis though skin microchannels created by microneedles. Calcein and human growth hormone were used as a model small and large molecule, respectively. In vitro permeation studies were performed on porcine ear skin under three different settings: (a) modulated iontophoresis alone, (b) pretreatment with microneedles and (c) combination of microneedles pretreatment and modulated iontophoresis. For modulated iontophoresis, 0.5 mA/cm(2) current was applied for 1h each at 2nd and 6th hour of the study. Methylene blue staining, calcein imaging and pore permeability index suggested maltose microneedles created uniform microchannels in skin. Application of iontophoresis provided two peaks in flux of 1.04 μg/(cm(2)h) at 4th hour and 2.09 μg/(cm(2)h) at 8th hour of study for calcein. These peaks in flux were significant higher when skin was pretreated with microneedles (p<0.05). Similarly, for human growth hormone, modulation in transdermal flux was achieved with combination of microneedles and iontophoresis. This combination also provided significant increase in cumulative amount of calcein and human growth hormone delivered as compared to microneedles or iontophoresis alone (p<0.05). Therefore, iontophoresis can be used to modulate drug delivery across skin microchannels created by microneedles.

[1]  D. Kobayashi,et al.  Acoustic cavitation as an enhancing mechanism of low-frequency sonophoresis for transdermal drug delivery. , 2009, Biological & pharmaceutical bulletin.

[2]  Yukako Ito,et al.  Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. , 2008, Biological & pharmaceutical bulletin.

[3]  R. Boinpally,et al.  Iontophoresis of lecithin vesicles of cyclosporin A. , 2004, International journal of pharmaceutics.

[4]  Mark R. Prausnitz,et al.  Effect of Microneedle Design on Pain in Human Volunteers , 2008, The Clinical journal of pain.

[5]  Göran Stemme,et al.  Painless Drug Delivery Through Microneedle-Based Transdermal Patches Featuring Active Infusion , 2008, IEEE Transactions on Biomedical Engineering.

[6]  A. Banga,et al.  Transdermal delivery of a ~13 kDa protein—an in vivo comparison of physical enhancement methods , 2009, Journal of drug targeting.

[7]  M. Thorner,et al.  Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. , 1997, The Journal of clinical endocrinology and metabolism.

[8]  Takashi Nakamura,et al.  Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Lutz Heinemann,et al.  Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. , 2011, Diabetes technology & therapeutics.

[10]  Desmond I. J. Morrow,et al.  Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers. , 2010, Photodiagnosis and photodynamic therapy.

[11]  O. Pillai,et al.  Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[13]  P. Friden,et al.  Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin. , 2010, International journal of pharmaceutics.

[14]  J. Moan,et al.  Microneedle Pre-treatment of Human Skin Improves 5-Aminolevulininc Acid (ALA)- and 5-Aminolevulinic Acid Methyl Ester (MAL)-Induced PpIX Production for Topical Photodynamic Therapy Without Increase in Pain or Erythema , 2010, Pharmaceutical Research.

[15]  Scott A. Kaestner,et al.  Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs , 2010, Pharmaceutical Research.

[16]  J. Bouwstra,et al.  In vivo assessment of safety of microneedle arrays in human skin. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  Rohit Bhargava,et al.  Characterization of porcine skin as a model for human skin studies using infrared spectroscopic imaging. , 2011, The Analyst.

[18]  A. Chaturvedula,et al.  In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin. , 2005, International journal of pharmaceutics.

[19]  M. Phillip,et al.  Transdermal Delivery of Human Growth Hormone Through RF-Microchannels , 2005, Pharmaceutical Research.

[20]  Bai Xu,et al.  Controlled transdermal delivery of model drug compounds by MEMS microneedle array. , 2005, Nanomedicine : nanotechnology, biology, and medicine.

[21]  M. Delgado-Charro,et al.  Electroosmotic transport of mannitol across human nail during constant current iontophoresis , 2010, The Journal of pharmacy and pharmacology.

[22]  Scott A. Burton,et al.  Rapid Intradermal Delivery of Liquid Formulations Using a Hollow Microstructured Array , 2010, Pharmaceutical Research.

[23]  Jonathan Hadgraft,et al.  Pig Ear Skin ex Vivo as a Model for in Vivo Dermatopharmacokinetic Studies in Man , 2006, Pharmaceutical Research.

[24]  Mark R Prausnitz,et al.  Dissolving microneedle patch for transdermal delivery of human growth hormone. , 2011, Small.

[25]  K. Sugibayashi,et al.  Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[26]  J. Weaver,et al.  Non-linearity of molecular transport through human skin due to electric stimulus. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[27]  J. Weaver,et al.  Imaging of fluorescent molecule and small ion transport through human stratum corneum during high voltage pulsing: localized transport regions are involved. , 1996, Biophysical chemistry.

[28]  F. Frézard,et al.  New insights into the mode of action of ultradeformable vesicles using calcein as hydrophilic fluorescent marker. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Jung-Hwan Park,et al.  Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Richard H Guy,et al.  Noninvasive glucose monitoring by reverse iontophoresis in vivo: application of the internal standard concept. , 2004, Clinical chemistry.

[31]  A. Banga,et al.  Electrically Modulated Transdermal Delivery of Fentanyl , 2002, Pharmaceutical Research.

[32]  Chandra Sekhar Kolli,et al.  Characterization of Solid Maltose Microneedles and their Use for Transdermal Delivery , 2007, Pharmaceutical Research.

[33]  James C. Birchall,et al.  Microneedles in Clinical Practice–An Exploratory Study Into the Opinions of Healthcare Professionals and the Public , 2010, Pharmaceutical Research.

[34]  V. Koul,et al.  Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin , 2010, Drug development and industrial pharmacy.

[35]  P. Santi,et al.  Effect of lipopeptides and iontophoresis on aciclovir skin delivery , 2010, The Journal of pharmacy and pharmacology.

[36]  A. Banga Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies , 2011 .

[37]  S. Dubey,et al.  Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Robert Langer,et al.  Transdermal drug delivery , 2008, Nature Biotechnology.

[39]  R. Guy,et al.  lontophoretic Permselectivity of Mammalian Skin: Characterization of Hairless Mouse and Porcine Membrane Models , 1998, Pharmaceutical Research.

[40]  N. Dixit,et al.  Iontophoresis - an approach for controlled drug delivery: a review. , 2007, Current drug delivery.

[41]  R H Guy,et al.  Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. , 2002, Journal of pharmaceutical sciences.

[42]  B. Ongpipattanakul,et al.  Characterization of the pore transport properties and tissue alteration of excised human skin during iontophoresis. , 1988, Journal of pharmaceutical sciences.

[43]  J. Eppstein,et al.  Transdermal Delivery of Interferon Alpha-2B using Microporation and Iontophoresis in Hairless Rats , 2007, Pharmaceutical Research.

[44]  R. Guy,et al.  Iontophoretic transport pathways: dependence on penetrant physicochemical properties. , 1997, Journal of pharmaceutical sciences.

[45]  D. Kobayashi,et al.  Synergistic Effects of Iontophoresis and Jet Injector Pretreatment on the In‐vitro Skin Permeation of Diclofenac and Angiotensin II , 2000, The Journal of pharmacy and pharmacology.

[46]  K. Feingold,et al.  Iontophoresis itself on hairless mouse skin induces the loss of the epidermal calcium gradient without skin barrier impairment. , 1998, The Journal of investigative dermatology.

[47]  Choh Hao Li Human growth hormone: 1974–1981 , 2004, Molecular and Cellular Biochemistry.

[48]  M. Gulisano,et al.  Transdermal Delivery of Heparin Using Pulsed Current Iontophoresis , 2006, Pharmaceutical Research.

[49]  H. Maibach,et al.  The Pig as an Experimental Animal Model of Percutaneous Permeation in Man: Qualitative and Quantitative Observations – An Overview , 2000, Skin Pharmacology and Physiology.

[50]  A. Banga,et al.  In vitro and in vivo iontophoretic transdermal delivery of an anti-parkinsonian agent. , 2011, International journal of pharmaceutics.

[51]  Kyoung-Mi Park,et al.  Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. , 2010, Antiviral research.

[52]  T. Annaswamy,et al.  Effect of Lidocaine Iontophoresis on Pain During Needle Electromyography , 2011, American journal of physical medicine & rehabilitation.

[53]  Haripriya Kalluri,et al.  Formation and Closure of Microchannels in Skin Following Microporation , 2010, Pharmaceutical Research.

[54]  P. Uzor,et al.  Perspectives on Transdermal Drug Delivery , 2011 .

[55]  A H Jeske,et al.  Iontophoresis: applications in transdermal medication delivery. , 1995, Physical therapy.

[56]  Mark R Prausnitz,et al.  Infusion pressure and pain during microneedle injection into skin of human subjects. , 2011, Biomaterials.

[57]  K. Kominami,et al.  In‐vitro and in‐vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic , 2011, The Journal of pharmacy and pharmacology.

[58]  A. Banga,et al.  Iontophoresis of a 13 kDa protein monitored by subcutaneous microdialysis in vivo. , 2011, Bioanalysis.

[59]  Ryan F. Donnelly,et al.  Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro , 2009, Pharmaceutical Research.

[60]  R. Ozaki,et al.  A new tool to detect kidney disease in Chinese type 2 diabetes patients: comparison of EZSCAN with standard screening methods. , 2011, Diabetes technology & therapeutics.

[61]  Juergen Lademann,et al.  Porcine ear skin: an in vitro model for human skin , 2007, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[62]  Zhengrong Cui,et al.  Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin , 2011, International journal of nanomedicine.